Right to Try Clarification Act
Bill journey · stage 2 of 5
Under committee review
What it doesSummary introduced in house (Jul 20, 2022)
Right to Try Clarification Act
This bill specifies that investigational drugs that are provided directly to individuals from manufacturers without the need for federal regulatory approval (i.e., via the Right to Try pathway) are exempt from restrictions that would otherwise apply under the Controlled Substances Act (e.g., restrictions on the use or possession of schedule I controlled substances).
What just happenedNov 1, 2022
Referred to the Subcommittee on Crime, Terrorism, and Homeland Security.
Who’s behind it
- Introduced in HouseJul 20, 2022
- Nov 1, 2022Committee
Referred to the Subcommittee on Crime, Terrorism, and Homeland Security.
Crime and Federal Government Surveillance Subcommittee - Jul 20, 2022IntroReferralH11100
Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Judiciary Committee - Jul 20, 2022IntroReferralH11100
Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Energy and Commerce Committee - Jul 20, 2022IntroReferralB00100
Sponsor introductory remarks on measure. (CR E757)
- Jul 20, 2022IntroReferralIntro-H
Introduced in House
- Jul 20, 2022IntroReferral1000
Introduced in House